BHCBausch Health Companies Inc.
$6.45+7.3% 1Y
$6.45
$4.4452 weeks$7.90
Is the price fair?
What BHC's price assumes
Bausch Health Companies Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.17× revenue.
0.17
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 1.91
EV / sales
Details›
- EV / EBITas of 2026-Q2
- 23.5
- EV / salesas of 2026-Q2
- 1.91
- Market capitalisation374.0 million shares, counted Jul 24, 2026
- $2.41B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #12 of 39 by RyuScore